Interventions for valvular disease
Impact of implant depth on hydrodynamic function of the ALLEGRA bioprosthesis in valve-in-valve interventions February 7, 2020 | 10.4244/EIJ-D-19-00782
Showing 1-6 of 6 articles
Interventions for valvular disease
Reference dimensions to determine valve size of stented surgical aortic bioprostheses by computed tomography February 4, 2020 | 10.4244/EIJ-D-19-00921
Interventions for valvular disease
Early experience with a purpose-designed temporary pacing guidewire for transcatheter valve implantation August 9, 2019 | 10.4244/EIJ-D-19-00138
Interventions for valvular disease
Impact of implant depth on hydrodynamic function with the ACURATE neo transcatheter heart valve following valve-in-valve transcatheter aortic valve replacement in Mitroflow bioprosthetic valves: an ex vivo bench study May 20, 2019 | 10.4244/EIJ-D-18-00947
Interventions for valvular disease
First-in-human experience of a new-generation transfemoral transcatheter aortic valve for the treatment of severe aortic regurgitation: the J-Valve transfemoral system February 7, 2019 | 10.4244/EIJ-D-18-00935
Culotte stenting for coronary bifurcation lesions with 2nd and 3rd generation everolimus-eluting stents: the CELTIC Bifurcation Study
June 14, 2018 | 10.4244/EIJ-D-18-00346